Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation

Molecular Cell

Volumn 12, Issue 2, 2003, Pages 381-392

  Welcker, Markus ^a   Singer, Jeffrey ^d   Loeb, Keith R ^a   Grim, Jonathan ^a   Bloecher, Andrew ^a   Gurien West, Mark ^a   Clurman, Bruce E ^a,c   Roberts, James M ^a,b,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLYCOGEN SYNTHASE KINASE 3; MUTANT PROTEIN; RECEPTOR SUBUNIT; UBIQUITIN PROTEIN LIGASE;

AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR MODEL; NONHUMAN; PEPTIDE MAPPING; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALIA;

EID: 0141591688     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00287-9     Document Type: Article

References (47)

1. Alt J.R., Cleveland J.L., Hannink M., Diehl J.A. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:2000;3102-3114.
2. Botz J., Zerfass-Thome K., Spitkovsky D., Delius H., Vogt B., Eilers M., Hatzigeorgiou A., Jansen-Durr P. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:1996;3401-3409.
3. Clurman B.E., Sheaff R.J., Thress K., Groudine M., Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1996;1979-1990.
4. Cohen P., Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:2001;769-776.
5. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3 β structural basis for phosphate-primed substrate specificity and autoinhibition Cell. 105:2001;721-732.
6. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:1998;3499-3511.
7. Donnellan R., Chetty R. Cyclin E in human cancers. FASEB J. 13:1999;773-780.
8. Dulic V., Lees E., Reed S.I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 257:1992;1958-1961.
9. Duronio R.J., O'Farrell P.H. Developmental control of the G1 to S transition in Drosophila. cyclin E is a limiting downstream target of E2F Genes Dev. 9:1995;1456-1468.
10. Duronio R.J., O'Farrell P.H., Xie J.E., Brook A., Dyson N. The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9:1995;1445-1455.
11. Ekholm S.V., Zickert P., Reed S.I., Zetterberg A. Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol. Cell. Biol. 21:2001;3256-3265.
12. Feldman R.M., Correll C.C., Kaplan K.B., Deshaies R.J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell. 91:1997;221-230.
13. Fiol C.J., Mahrenholz A.M., Wang Y., Roeske R.W., Roach P.J. Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J. Biol. Chem. 262:1987;14042-14048.
14. Frame S., Cohen P., Biondi R.M. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell. 7:2001;1321-1327.
15. Geng Y., Eaton E.N., Picon M., Roberts J.M., Lundberg A.S., Gifford A., Sardet C., Weinberg R.A. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1996;1173-1180.
16. Hansen K., Farkas T., Lukas J., Holm K., Ronnstrand L., Bartek J. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block. EMBO J. 20:2001;422-432.
17. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell. 98:1999;859-869.
18. Keyomarsi K., Herliczek T.W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 3:1997;171-191.
19. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA. 93:1996;8455-8459.
20. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science. 294:2001;173-177.
21. Koff A., Giordano A., Desai D., Yamashita K., Harper J.W., Elledge S., Nishimoto T., Morgan D.O., Franza B.R., Roberts J.M. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science. 257:1992;1689-1694.
22. Lukas J., Sorensen C.S., Lukas C., Santoni-Rugiu E., Bartek J. p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest. molecular mechanisms and implications for oncogenesis Oncogene. 18:1999;3930-3935.
23. Lundberg A.S., Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:1998;753-761.
24. Matsushime H., Quelle D.E., Shurtleff S.A., Shibuya M., Sherr C.J., Kato J.Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:1994;2066-2076.
25. Minella A.C., Swanger J., Bryant E., Welcker M., Hwang H., Clurman B.C. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr. Biol. 12:2002;1817-1827.
26. Moberg K.H., Bell D.W., Wahrer D.C., Haber D.A., Hariharan I.K. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature. 413:2001;311-316.
27. Nash P., Tang X., Orlicky S., Chen Q., Gertler F.B., Mendenhall M.D., Sicheri F., Pawson T., Tyers M. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature. 414:2001;514-521.
28. Ohtani K., DeGregori J., Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:1995;12146-12150.
29. Ohtsubo M., Roberts J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science. 259:1993;1908-1912.
30. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:1995;2612-2624.
31. Porter P.L., Malone K.E., Heagerty P.J., Alexander G.M., Gatti L.A., Firpo E.J., Daling J.R., Roberts J.M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 3:1997;222-225.
32. Resnitzky D., Gossen M., Bujard H., Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1994;1669-1679.
33. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1997;1464-1478.
34. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
35. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
36. Singer J.D., Gurian-West M., Clurman B., Roberts J.M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13:1999;2375-2387.
37. Skowyra D., Craig K.L., Tyers M., Elledge S.J., Harper J.W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell. 91:1997;209-219.
38. Spruck C.H., Won K.A., Reed S.I. Deregulated cyclin E induces chromosome instability. Nature. 401:1999;297-300.
39. Spruck C.H., Strohmaier H., Sangfelt O., Muller H.M., Hubalek M., Muller-Holzner E., Marth C., Widschwendter M., Reed S.I. hCDC4 gene mutations in endometrial cancer. Cancer Res. 62:2002;4535-4539.
40. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6:1996;1664-1668.
41. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature. 413:2001;316-322.
42. Sullivan S., Wong T.W. A manual sequencing method for identification of phosphorylated amino acids in phosphopeptides. Anal. Biochem. 197:1991;65-68.
43. ter Haar E., Coll J.T., Austen D.A., Hsiao H.M., Swenson L., Jain J. Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8:2001;593-596.
44. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
45. Verma R., Annan R.S., Huddleston M.J., Carr S.A., Reynard G., Deshaies R.J. Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase. Science. 278:1997;455-460.
46. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
47. Won K.A., Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15:1996;4182-4193.